Crescent Biopharma, Inc. Common Stock (CBIO) News

Latest headlines that mention CBIO, newest first · each headline opens the original publisher

CBIO quote

Last price: $11.84
Day change: -5.13%
Next earnings: 2026-11-05

Quote & chart Expected move Insider trading IV rank history

CBIO headlines

latest coverage

Seeking Alpha News 21d ago

The Nascent Crescent Biopharma Thesis: One Year Later And Things Are Steady

General T2CBIO

Seeking Alpha News 1mo ago

Crescent Biopharma, Inc. (CBIO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

General T2CBIO

Investing.com 1mo ago

Crescent Biopharma at Morgan Stanley conference: pipeline bets build

General T3CBIO

Investing.com 1mo ago

Crescent Biopharma at Cantor conference: global trial push

General T3CBIO

Investing.com 2mo ago

Crescent Biopharma earnings beat by $0.04, revenue topped estimates

Earnings T3CBIO

Seeking Alpha 3mo ago

Crescent Biopharma files for underwritten offering of ordinary shares and pre-funded warrants

General T2CBIO

Seeking Alpha News 3mo ago

Crescent Biopharma: Intriguing Developer Of ADC/PD1-VEGF Assets May Not Be Sufficiently Derisked

General T2CBIO

Investing.com 3mo ago

Form 4 Crescent Biopharma Inc For: 23 June

General T3CBIO

Investing.com 3mo ago

Crescent Biopharma CFO Scalzo sells $20,004 in shares

General T3CBIO

Investing.com 3mo ago

Crescent Biopharma general counsel sells $21,911 in shares

General T3CBIO

Investing.com 4mo ago

H.C. Wainwright downgrades Crescent Biopharma stock rating to neutral

General T3CBIO

CBIO news alerts

Get an alert by email or push when a new headline mentions CBIO.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.